НовостиBenzingaZealand Pharma Says EC Grants Marketing Authorization For Zeydovio, Long-Acting, Next-Gen GLP-2 Analog, For Treatment Of Adults With Short Bowel Syndrome Zealand Pharma Says EC Grants Marketing Authorization For Zeydovio, Long-Acting, Next-Gen GLP-2 Analog, For Treatment Of Adults With Short Bowel Syndrome Benzinga 2026.11.13 15:01 (GMT+0) Открыть на Benzinga Другие новости